Copyright © 2001 by the European Society of Cardiology.
Editorials
A monk's prayer: O Lord what is the answer to in-stent restenosis? Commentary on the TRAPIST Study
Mayo Clinic and Mayo Foundation, Rochester, Minnesota, U.S.A.
References
- Hoshiya Makiko, Awazu Midori. Trapidil inhibits platelet-derived growth factor stimulated mitogen activated protein kinase cascade. Hypertension. 1998;31:6671
- Cercek B, Ebrahimi R, Dimayuga P, Khorsandi M, Forrester JS. Trapidil reverses rat vascular smooth muscle cell proliferation in vitro and in vivo (Abstr). J Am Coll Cardiol. 1991;17:72A
- Brenner DJ, Miller RC. Long-term efficacy of intracoronary irradiation in inhibiting in-stent restenosis. Circulation. 2001;103:13301332
[Abstract/Free Full Text] - Kim HS, Waksman R, Cottin Y. Edge stenosis and geographical miss following intracoronary gamma radiation therapy for in-stent restenosis. J Am Coll Cardiol. 2001;37:10261030
[Abstract/Free Full Text] - Serruys PW, Foley DP, Pieper M, Kleijne JA, de Feyter PJ. The TRAPIST study. A multicentre randomized placebo controlled clinical trial of trapidil for prevention of restenosis after coronary stenting, measured by 3-D intravascular ultrasound. Eur Heart J. 2001;22:19381947
[Abstract/Free Full Text] - Drachman DE, Edelman ER, Seifert P. Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months. J Am Coll Cardiol. 2000;36:23252332
[Abstract/Free Full Text] - Sousa JE, Costa MA, Abizaid A. Lack of intimal response after implantation of sirolimus-coated stents in human coronary arteries : a QCA and 3-D IVUS study. Circulation. 2001;103:192195
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||